Evaluate the Safety, Tolerability and Pharmacokinetics of DW5524 in Healthy Adult Volunteers

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C

NCT05465668 ·Status: COMPLETED ·Phase: PHASE1

DWP05195 in Healthy Adult Male Volunteers

NCT00969787 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fed Condition

NCT01589562 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fed State

NCT07342062 ·Status: COMPLETED ·Phase: PHASE1

Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fasting State

NCT05739903 ·Status: UNKNOWN ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean

NCT03574415 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19

NCT04524052 ·Status: UNKNOWN ·Phase: PHASE1

Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers

NCT04827472 ·Status: UNKNOWN ·Phase: PHASE1

The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects

NCT05607589 ·Status: WITHDRAWN ·Phase: PHASE1

To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003

NCT04592835 ·Status: UNKNOWN ·Phase: PHASE1

A Clinical Trial to Evaluate Pharmacokinetics of Daewon DW-ES(A) 625mg/5ml, Daewon DW-ES(B) 625mg/5ml and Megace 800mg/20ml in Healthy Male Volunteers Under Fed Condition

NCT01383330 ·Status: UNKNOWN ·Phase: PHASE1

Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male Volunteers

NCT02097043 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate the PK, PD, Safety and Drug Tolerance of JW0302 in Healthy Volunteers

NCT05784155 ·Status: COMPLETED ·Phase: PHASE1

A Single Dose Study of DWP10292 in Healthy Male Subjects

NCT01423526 ·Status: COMPLETED ·Phase: PHASE1

A Study to Compare and Evaluate the Safety, Tolerability and Pharmacokinetics Between DA-5223 and DA-5223-R in Healthy Adult Subjects

NCT07007533 ·Status: COMPLETED ·Phase: PHASE1

A Study of ACE-2494 in Healthy Subjects

NCT03478319 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809

NCT05214677 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fasting and Fed Condition

NCT01456624 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate the PK, PD, Safety and Drug Tolerance in Healthy Volunteers

NCT05433844 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (DA-2811)

NCT04938752 ·Status: COMPLETED ·Phase: PHASE1

Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers

NCT01952548 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate the Safety and the Pharmacokinetics of NVP-2203

NCT05725252 ·Status: COMPLETED ·Phase: PHASE1

Study of TAVO101 in Healthy Volunteers

NCT05298046 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety of K-755 in Healthy Volunteers

NCT03414294 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects

NCT04525079 ·Status: COMPLETED ·Phase: PHASE1